Angiogenex Inc AGGX:Over The Counter Market

Last Price$0.13Over The Counter Market Previous Close - Last Trade as of 2:37PM ET 8/27/21

Today's Change0.00(0.00%)
Bid (Size)$0.0002 (10,000)
Ask (Size)$0.40 (2,500)
Day Low / High$0.13 - 0.13
Volume2.2 K

View Biotechnology IndustryPeer Comparison as of 08/27/2021


Angiogenex Inc ( OTC )

Price: $0.13
Change: 0.00 (0.00%)
Volume: 2.2 K
2:37PM ET 8/27/2021

ACI Global Corp ( OTC )

Price: $0.005
Change: 0.00 (0.00%)
Volume: 80.00
2:12PM ET 7/29/2021

Swiftsure International Inc ( OTC )

Price: $0.03
Change: 0.00 (0.00%)
Volume: 5.00
9:17AM ET 6/03/2021

Protide Pharmaceuticals Inc ( OTC )

Price: $0.22
Change: 0.00 (0.00%)
Volume: 112.00
1:55PM ET 9/15/2021

Nuo Therapeutics Inc ( OTC )

Price: $0.04
Change: 0.00 (0.00%)
Volume: 18.00
9:21AM ET 9/27/2021

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionAngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra on March 31, 1999 and is headquartered in New York, NY. View company web site for more details
Address425 Madison Avenue
New York, New York 10017
Number of EmployeesN/A
Chairman, President & Chief Executive OfficerMichael Charles Aronstein
Chief Operations Officer, Director & VPMichael M. Strage
Chief Financial Officer & DirectorMartin F. Murray

Company Highlights

Price Open$0.13
Previous Close$0.13
52 Week Range$0.03 - 0.40
Market Capitalization$4.0 M
Shares Outstanding30.4 M
SectorHealth Technology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.03
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity84.00%